Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD
Frontiers in Immunology · 15.06.2026 · 17
DOI: 10.3389/fimmu.2026.1860892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 15.06.2026. Verfasst von Yike Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, United States. Hauptthemen laut MEDLINE: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Encephalomyelitis, Autoimmune, Experimental, Myelin-Oligodendrocyte Glycoprotein, Immunoglobulin G. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a severe, autoantibody-mediated neuroinflammatory syndrome that disproportionately impacts children. Detection of conformation-specific anti-MOG IgG1 in the serum is central to MOGAD diagnosis, yet the pathogenic role of these antibodies remains unclear. We sought to develop a clinically informed model of pediatric MOGAD to study the immunopathogenesis that recapitulates 1) early age of disease onset, 2) anti-MOG IgG1 in serum, and 3) widespread inflammation in the CNS.
Methods
We employed two approaches to model MOGAD using anti-MOG IgG in mice: 1) treating young C57BL/6 mice with the murine-derived monoclonal MOG antibody 8-18C5, and 2) using young IgH MOG transgenic (Tg) mice, engineered to express the immunoglobulin heavy chain of 8-18C5. These mice were induced with experimental autoimmune encephalomyelitis (EAE) by immunizing with MOG 35–55 to elicit inflammatory demyelination.
Results
Both exogenous and endogenous anti-MOG IgG exacerbated EAE disease in young mice. Compared to wild-type littermates (+/+), young IgH MOG Tg mice (Tg/+) exhibited reduced peripheral immune cells and greater neutrophil-to-lymphocyte ratios. Tg/+ mice also had increased CNS leukocyte infiltration compared to wild-type littermates. Tg/+ mice developed monophasic circumferential longitudinal myelitis, bilateral optic neuritis, and multifocal brain inflammation. Innate immune cells in the CNS, including microglia, showed significant downregulation of surface FcγRII/III. This downregulation on microglia was accompanied by enhanced uptake of cells expressing MOG, suggesting Fc receptor-mediated internalization of MOG immune complexes.
Discussion
Introduction of anti-MOG IgG in EAE recapitulates key aspects of pediatric MOGAD and enables dissection of the mechanisms underlying anti-MOG antibody-mediated immunopathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, United States.
- Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
- Department of Molecular Genetics & Microbiology, Duke University School of Medicine, Durham, NC, United States.
- Department of Cell Biology, Duke University School of Medicine, Durham, NC, United States.
- Department of Neurobiology, Duke University School of Medicine, Durham, NC, United States.
Zitieren
APA
Jiang, Y., Reyes, E. Y., Lin, E. Y., Troutman, E. C., Lumbreras, M., DiPalma, D. T., Van Mater, H., & Shinohara, M. L. (2026). Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1860892
Vancouver
Jiang Y, Reyes EY, Lin EY, Troutman EC, Lumbreras M, DiPalma DT, et al. Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1860892
BibTeX
@article{Jiang2026,
author = {Jiang, Yike and Reyes, Estefany Y and Lin, Elliot Yh and Troutman, Emily C and Lumbreras, Miranda and DiPalma, Devon T and Van Mater, Heather and Shinohara, Mari L},
title = {Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1860892}
}
EUVIMED